COSCIENS Biopharma Inc. (CSCIF) shareholders
CSCIFOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Mar 31, 2026Last filing: 20-F on Mar 25, 2026Score 1/30
$6.49+0.00 (0.00%)
Close on Oct 19, 2026Market cap $24.10MP/E –Yield –
Ownership
Institutional holdings as of Dec 31, 2025, from 13F filings
Held by institutions
0.0%
0M of 3M shares
Institutional holders
0
0 new, 2 sold out
Net institutional buying
-0M
In Q4 2025
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Goodwood Fund Joint filing with Goodwood Inc. (8.20%), Peter Puccetti (8.20%) and 1 more | 257,257 | 8.20% | 13D (active) amendment | Dec 19, 2024 |
| Peter Puccetti Joint filing with Goodwood Fund (8.20%), Goodwood Inc. (8.20%) and 1 more | 257,257 | 8.20% | 13D (active) amendment | May 30, 2025 |
Top institutional holders
13F holdings as of Sep 30, 2025
| Holder | Shares | % of CSCIF | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| TD Waterhouse Canada Inc. | 3,860 | 0.12% | $10.15K | – | 0.00% |
| Osaic Holdings, Inc. | 50 | 0.00% | $153 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q4 2025 | 0 | 0M | 0.0% | 0 / 0 | 0 / 2 | 0M | 0M |
| Q3 2025 | 2 | 0M | 0.1% | 0 / 0 | 0 / 13 | 0M | 0M |
| Q2 2025 | 15 | 0M | 1.0% | 1 / 4 | 3 / 1 | 0M | 0M |
| Q1 2025 | 15 | 0M | 0.9% | 2 / 2 | 4 / 2 | 0M | 0M |
| Q4 2024 | 15 | 0M | 0.7% | 8 / 2 | 1 / 1 | 0M | 0M |
| Q3 2024 | 9 | 0M | 0.5% | 9 / 0 | 0 / 0 | 0M | 0M |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
0M shares short
Days to cover
4.3
At 0M shares a day
Change since last report
-21.3%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of COSCIENS Biopharma's stock actually held short. Settlement fails (shares not delivered on time) peaked at 273 shares on Oct 14, 2026 over the last 90 days.
Congress trades
2 trades in COSCIENS Biopharma reported by 1 member of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Roger W. Marshall KS01 · child | Sold | Jul 20, 2017 | $1K–15K | Aug 6, 2018 382 days late |
| Roger W. Marshall KS01 · child | Bought | Jul 19, 2017 | $1K–15K | Aug 6, 2018 383 days late |
See a number that looks wrong?